Vanta Bioscience Limited (BOM:540729)
20.40
-0.02 (-0.10%)
At close: Oct 16, 2026
Vanta Bioscience Revenue
In the fiscal year ending March 31, 2026, Vanta Bioscience had annual revenue of 18.16M INR with 61.11% growth. Vanta Bioscience had revenue of 15.15M in the half year ending March 31, 2026, a decrease of -56.94%. That makes Vanta Bioscience the 45,483rd largest company in the world by revenue and 4,908th in India.
Revenue
18.16M
Revenue Growth
+61.11%
P/S Ratio
7.99
Revenue / Employee
477.99K
Employees
38
Market Cap
145.08M
Revenue by Geography
- India 15.64M 86.1%
- Export 2.31M 12.7%
- Unallocated 215.90K 1.2%
Fiscal year ended Mar 31, 2026 See the full Vanta Bioscience breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.16M | 6.89M | 61.11% |
| Mar 31, 2025 | 11.27M | -85.95M | -88.40% |
| Mar 31, 2024 | 97.23M | 34.47M | 54.92% |
| Mar 31, 2023 | 62.76M | -37.42M | -37.36% |
| Mar 31, 2022 | 100.18M | -331.33K | -0.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Olympia Industries | 3.39B |
| Tandhan Industries | 1.61B |
| Astron Multigrain | 484.03M |
| Kizi Apparels | 426.36M |
| EP Biocomposites | 136.40M |
| Cosyn | 112.27M |
| Bharat Bhushan Finance & Commodity Brokers | 9.63M |
| Northlink Fiscal and Capital Services | 7.40M |